Form 8-K JOHNSON & JOHNSON For: Nov 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Johnson & Johnson (JNJ) transition underway, UBS assesses upcoming analyst day
December 1, 2023 9:05 AM ESTUBS maintained Johnson & Johnson (NYSE: JNJ) at Buy with a $180 per share price target on Friday in its analyst day preview note.
The firm said it expects the company to reiterate its pharma guide, while its MedTech guide will at... More
